Induction of cytotoxic T-cell responses by gene gun DNA vaccination with minigenes encoding influenza A virus HA and NP CTL-epitopes

Vaccine

Volumn 18, Issue 7-8, 1999, Pages 681-691

  Fomsgaard, Anders ^a   Nielsen, Henrik V ^a   Kirkby, Nikolai ^a   Bryder, Karin ^a   Corbet, Sylvie ^a   Nielsen, Claus ^a   Hinkula, Jorma ^b   Buus, Søren ^c  

^a STATENS SERUM INSTITUT   (Denmark)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

CTL; DNA vaccine; Influenza; Minigenes

Indexed keywords

DNA VACCINE; EPITOPE; HEPATITIS B SURFACE ANTIGEN; INFLUENZA VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS HEMAGGLUTININ; VIRUS NUCLEOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; FEMALE; GENE GUN; INFLUENZA VACCINATION; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BIOLISTICS; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; FEMALE; GENES, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS; INFLUENZA VACCINES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED CBA; NUCLEOCAPSID PROTEINS; NUCLEOPROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA; VIRAL CORE PROTEINS; VIRAL STRUCTURAL PROTEINS;

EID: 0032732551     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00279-0     Document Type: Article

References (33)

1. Ito T., Couceiro J.N.S.S., Kelm S., Baum L.G., Krauss S., Castrucci M.R., Donatelli I., Kida H., Paulson J.C., Webster R.G., Kawaoka Y. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J. Virol. 72:1998;7367-7373.
2. Yap K.C., Ada G.C., McKenzie I.F.C. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature. 273:1978;238-239.
3. Doherty P.C., Allan M., Eichberger M., Carding S.R. Roles of αβ and γδ T cell subsets in viral immunity. Annu. Rev. Immunol. 10:1992;123-151.
4. Schreiber H. Tumor immunology. Paul W.E. Fundamental immunology. 3rd ed. 1993;1143-1178 Raven Press, New York.
5. Kaufmann S.H. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:1993;129-163.
6. Webster R.G., Robinson H.L. DNA vaccines. A review of developments. Biopharmaceuticals. 4:1997;273-292.
7. Tighe H., Corr M., Roman M., Raz E. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol. Today. 19:1998;89-97.
8. Thomson S.A., Elliot S.L., Sherritt M.A., Sproat K.W., Coupar B.E.H., Scalzo A.A., Forbes C.A., Ladhams A.M., Mo X.Y., Tripp R.A., Doherty P.C., Moss D.J., Suhrbier A. Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes. J. Immunol. 22:1996;822-826.
9. Restifo N.P., Bacik I., Irvive K.R., Yewdell J.W., McCabe B.J., Anderson R.W., Eisenlohr L.C., Rosenberg S.A., Bennink J.R. Antigen processing in vivo and the elicitation of primary CTL responses. J. Immunol. 154:1995;4414-4422.
10. Ciernik I.F., Berzofsky J.A., Carbone D.P. Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single cell epitopes. J. Immunol. 156:1996;2369-2375.
11. Hanke T., Schneider J., Gilbert S.C., Hill A.V.S., McMichael A. DNA multi-epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice. Vaccine. 16:1998;426-435.
12. Sweetser M.T., Morrison L.A., Braciale V.L., Braciale T.J. Recognition of pre-processed endogenous antigen by class I but not class II MHC-restricted T cells. Nature. 342:1989;180-182.
13. Gould K.G., Scotney H., Brownlee G.G. Characterization of two distinct major histocompatibility complex class I Kk-restricted T cell epitopes within the influenza A/PR/8/34 virus hemagglutinin. J. Virol. 65:1991;5401-5409.
14. Davis H.L., Michel M-L., Whalen R.G. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 2:1993;1847-1851.
15. Fomsgaard A., Nielsen H.V., Bryder K., Nielsen C., Machuca R., Bruun L., Hansen J., Buus S. Improved humoral and cellular immune responses against the gp120 V3 loop of HIV-1 following genetic immunization with a chimeric DNA vaccine encoding the V3 inserted into the hepatitis B surface antigen. Scand. J. Immunol. 47:1998;289-295.
16. Stryhn A., Pedersen L.Ø., Ortiz-Navarrete V., Buus S. Performed purified peptide/major histocompatibility class I complexes are potent stimulators of class I-restricted T cell hybridomas. Eur. J. Immunol. 24:1994;1404-1409.
17. Marker O., Volkert M. Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice. J. Exp. Med. 137:1973;1511-1513.
18. Fu T-M., Friedman A., Ulmer J.B., Liu M.A., Donelly J.J. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. J. Virol. 71:1997;2715-2721.
19. Kodihalli S., Haynes J.R., Robinson H.L., Webster R.G. Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin. J. Virol. 71:1997;3391-3396.
20. Ulmer J.B., Deck R.R., Dewitt C.M., Donnelly J.J., Liu M.A. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology. 89:1996;59-67.
21. Del Val M., Schlicht H.J., Volkmer H., Messerle M., Reddehase M.J., Koszinowski U.H. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighbouring residues in the protein. Cell. 66:1991;1145-1153.
22. Eisenlohr L.C., Yewdell J.W., Bennink J.R. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 175:1992;481-487.
23. Yellen-Shaw A.J., Wherry J.E., Dubois G.C., Eisenlohr L.C. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein. J. Immunol. 158:1997;3227-3234.
24. Hahn Y.S., Braciale V.L., Brachiale T.J. Presentation of viral antigen to class I major histocompatiliby complex-restricted cytotoxic T lymphocyte. Recognition of an immunodominant influenza hemagglutinin site by cytotoxic T lymphocyte in the hemagglutinin translation product. J. Exp. Med. 174:1991;733-735.
25. Shirai M., Chen M., Arichi T., Masaki T., Nishioka M., Newman M., Nakazawa T., Feinstone S.M., Berzofsky J.A. Use of intrinsic and extrinsic helper epitopes for induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines. J. Infect. Dis. 173:1996;24-30.
26. Borges E., Weismüller K-H., Jung G., Walden P. Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes comparison of the costimulating support provided by helper T cells and lipoamino acid. J. Immunol. Meth. 173:1994;253-263.
27. Jin Y., Shih J.W-K., Berkower I. Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen. J. Exp. Med. 168:1988;293-306.
28. Chimini G., Pala P., Sire J., Jordan B.R., Maryanski J.L. Recognition of oligonucleotide-encoded T-cell epitopes introduced into a gene unrelated to the original antigen. J. Exp. Med. 169:1989;297-302.
29. Lawson C.M., Bennink J.R., Restifo N.P., Yewdell J.W., Murphy B.R. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge. J. Virol. 68:1994;3505-3511.
30. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeVitt C.M., Friedman A., Hawe L.A., Leander K.R., Martinez D., Perry H.C., Shiver J.W., Montgomery D.L., Liu M.A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
31. Rodriguez F., An L.L., Harkins S., Zhang J., Yokoyama M., Widera G., Fuller J.T., Kincaid C., Cambell I., Whitton J.L. DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination. J. Virol. 72:1998;5174-5181.
32. Zarozinski C.C., Fynan E.F., Selin L.K., Robinson H.L., Welsh R.M. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardement with DNA encoding an internal virion protein. J. Immunol. 154:1995;4010-4017.
33. Moskophidis D., Kioussis D. Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J. Exp. Med. 2:1998;223-232.